New Methods to Evaluate Intestinal Drug Absorption Mediated by Oligopeptide Transporter from In vitro Study using Caco-2 Cells

Drug Metabolism and Pharmacokinetics

Volumn 17, Issue 5, 2002, Pages 408-415

  Yamashita, Shinji ^a   Hattori, Emiko ^a   Shimada, Aiko ^a   Endoh, Yoriko ^a   Yamazaki, Yukako ^a   Kataoka, Makoto ^a   Sakane, Toshiyasu ^a   Sezaki, Hitoshi ^a  

^a SETSUNAN UNIVERSITY   (Japan)

Author keywords

Caco 2 monolayers; competitive inhibition; cotransport; drug permeability; oligopeptide transporter

Indexed keywords

EID: 34249064082     PISSN: 13474367     EISSN: 18800920     Source Type: Journal    
DOI: 10.2133/dmpk.17.408     Document Type: Article

References (23)

1. Tsuji, A. and Tamai, I.: Carrier-mediated intestinal transport of drugs. Pharm. Res., 13: 963-977 (1996).
2. Dantzig, A. H. and Bergin, L.: Uptake of the cephalosporin, cephalexin, by a dipeptide transport carrier in the human intestinal cell line, Caco-2. Biochim. Biophys. Acta, 1027: 211-217 (1990).
3. Inui, K., Okano, T., Maegawa, H., Kato, M., Takano, M. and Hori, H.: H+ coupled transport of p.o. cephalosporins vs dipeptide carriers in rabbit intestinal brush-border membranes: difference of transport characteristics between cefixime and cephradine. J. Pharmacol. Exp. Ther., 247: 235-241 (1988).
4. Tamai, I., Tomizawa, T., Takeuchi, K., Nakayama, H., Higashida, H. and Tsuji, A.: Functional expression of transporter for beta-lactam antibiotics and dipeptides in xenopaus laevis oocytes injected with messenger RNA from human, rat and rabbit small intestine. J. Pharmacol. Exp. Ther., 273: 26-31 (1995).
5. Thwaites, D. T., Cavet, M., Hirst, B. H. and Simmons, N. L.: Angiotensin-converting enzyme (ACE) inhibitor transport in human intestinal epithelial (Caco-2) cells. British. J. Pharmacol., 114: 981-986 (1995).
6. Lennernas, H., Palm, K., Fagerholm, U. and Artursson, P.: Comparison between active and passive drug transport in human intestinal epithelial (Caco-2) cells in vitro and human jejunm in vivo. Int. J. Pharm., 127: 103-107 (1996).
7. Chong, S., Dando, S. A., Soucek, K. M. and Morrison, R. A.: In vitro permeability through Caco-2 cells is not quantitatively predictive of in vivo absorption for peptide-like drugs absorbed via dipeptide transporter system. Pharm. Res., 13: 120-123 (1996).
8. Yu, H., Cook, T. J. and Sinko, P. J.: Evidence for diminished functional expression of intestinal transporters in Caco-2 cell monolayers at high passages. Pharm. Res., 14: 757-762 (1997).
9. Hu, M., Zheng, L., Chen, J., Liu, L., Li, Y., Danzig, A. and Stanford, R. E. Jr.: Peptide transporter function and prolidase activities in Caco-2 cells: A lack of coordinate expression. J. Drug Targeting, 3: 291-300 (1995).
10. Hsu, C. H., Hilfinger, J., Walter, E., Merkle, H. P., Roessler, J. and Amidon, G.: Overexpression of human intestinal oligopeptide transporter in mammalian cells via acenoviral transduction. Pharm. Res., 15: 1376-1381 (1998).
11. Yamashita, S., Konishi, K., Yamazaki, Y., Taki, Y., Sakane, T., Sezaki, H. and Furuyama, Y.: New and better protocols for short-term Caco-2 cell culture system. J. Pharm. Sci., 91: 669-679 (2002).
12. Yamashita, S., Furubayashi, T., Kataoka, M., Sakane, T., Sezaki, H. and Tokuda, H.: Optimized conditions for prediction of intestinal drug permeability using Caco-2 cells. Eur. J. Pham. Sci., 10: 195-204 (2000).
13. Yamashita, S., Tanaka, Y., Endoh, Y., Taki, Y., Sakane, T., Nadai, T. and Sezaki, H.: Analysis of drug permeation across Caco-2 monolayers: implication for predicting in vitro drug absorption. Pharm. Res., 14: 486-491 (1997).
14. Sinko, P. J. and Amidon, G. L.: Characterization of the oral absorption of b-lactam antibiotics II: Competitive absorption and peptide carrier specificity. J. Pharm. Sci., 78: 723-727 (1989).
15. Matsumoto, S., Saitoh, H. and Inui, K.: Transport characteristics of cefutibuten, a new cephalosporin antibiotic, via the apical H + /dipeptide cotransport system in human intestinal cell line Caco-2: regulation by cell growth. Pharm. Res., 12: 1483-1487 (1995).
16. Muranushi, N., Yosikawa, T., Yoshida, M., Oguma, T., Hirano, K. and Yamada, H.: Transport characteristics of cefutibuten, a new oral cephem, on rat intestinal brush-border membrane vesicles: relationship to oligopeptide and amino b-lactam transport. Pham. Res., 6: 308-312 (1989).
17. Tsuji, A., Terasaki, T., Tamai, I. and Hirooka, H.: H + gradient-dependent and carrier-mediated transport of cefixime, a new cephalosporin antibiotic, across brush-border membrane vesicles from rat small intestine. J. Pharmacol. Exp. Ther., 241: 594-601 (1987).
18. Amidon, G. L., Sinko, P. J. and Fleisher, D.: Estimating Human Oral Fraction Dose Absorbed: a correlation using rat intestinal membrane permeability for passive and carrier-mediated compounds. Pharm. Res., 5: 651-654 (1988).
19. Bretchneider, B., Brandsch, M. and Neubert, R.: Intestinal transport of b-lactam antibiotics: analysis of the affinity at the H + /peptide symporter (PepT1), the uptake into Caco-2 cell monolayers and the transepithelial flux. Pharm. Res., 16: 55-61 (1999).
20. Friedman, D. I. and Amidon, G. L.: Intestinal absorption mechanism of dipeptide angiotensin converting enzyme inhibitors of the lysyl-proline type: lisinopeil and SQ 29,852. J. Pharm. Sci., 78: 995-998 (1989).
21. Duchin, K. L., Singhvi, S. M., Willard, D., Migdalof, B. H. and McKinstry, D. N.: Captpril kinetics. Clin Pharmacol. Ther., 31: 452-459 (1982).
22. Thwaites, D. T., Hirst, B. H. and Simmons, N. L.: Substrate specificity of the di/tripeptide transporter in human intestinal epithelia (Caco-2): identification of substrates that undergo H + -coupled absorption. British. J. Pharmacol., 113: 1050-1056 (1994).
23. Wenzel, U., Gebert, I., Weintraut, H., Weber, W. M., Claub, W. and Daniel, H.: Transport characteristics of differently charged cephalosporin antibiotics in oocytes expressing the cloned intestinal peptide transporter PepT1 and human intestinal Caco-2 cells. J. Pharmacol. Exp. Ther., 277: 831-839 (1996).